Table 5.
Common Herb-Drug Interactions
| Herb | Drug or Drug Class | Interaction or Other Comments |
|---|---|---|
| Comfrey | Phenobarbital | Increases metabolism of comfrey, producing a lethal metabolite from pyrrolizidine that results in severe hepatotoxicity |
| Danshen | Anticoagulants or antiplatelets | Increases bleeding due to additive effects |
| Digoxin | Increases side effects of digoxin | |
| Echinacea | Amiodarone or ibutilide | Increases QT interval |
| Statins, fibrates, niacin | Increases risk of hepatotoxic effects | |
| Ephedra | Antidiabetes drugs | Increases blood glucose; Decreases effectiveness of oral hypoglycemic agents |
| Class IA and class III antiarrhythmics | Increases QT interval | |
| β-Blockers | Decreases effects of β-blockers, leading to hypertension and tachycardia | |
| Monoamine oxidase inhibitors | Hypertension | |
| Evening primrose oil | Phenobarbital | Decreases seizure threshold |
| Garlic | Aspirin, clopidogrel, warfarin, or heparinoids | Increases bleeding risk |
| Ginkgo biloba | Antidiabetes drugs | Increases hypoglycemia |
| Aspirin | Increases bleeding; inhibits PAF hemorrhage | |
| Warfarin | ||
| Ginseng | Antidiabetes drugs | Increases hypoglycemia |
| Digoxin | Interferes with digoxin assay, leading to falsely increased levels | |
| Warfarin | Decreases effectiveness of warfarin | |
| Phenelzine sulfate | Headache; Irritability; Insomnia |
|
| Hawthorn | Digoxin | Increases effects of digoxin |
| Calcium channel blockers or nitrates | Increases coronary vasodilatory effects | |
| Kava | Alprazolam | Increases CNS depression; Increases effects of alcohol |
| Licorice | Spironolactone | Increases effects of spironolactone |
| Saw palmetto | Anticoagulants or antiplatelets | Increases bleeding |
| Soy milk | Warfarin | Decreases effectiveness of warfarin |
| St. John’s wort | Digoxin | Decreases serum digoxin concentration |
| Clopidogrel | Increases activity of clopidogrel; Increases bleeding |
|
| Warfarin | Decreases warfarin bioavailability and effectiveness | |
| Simvastatin | Decreases effectiveness of simvastatin | |
| Paroxetine | Nausea; Lethargy; Incoherence |
|
| Class IA and III antiarrhythmic agents | Decreases effectiveness (precipitating arrhythmias) | |
| Cyclosporine | Decreases cyclosporine concentration due to increased clearance (transplant rejection) | |
| Theophylline | Decreases serum concentration | |
| Indinavir | Decreases serum concentration (treatment failure in HIV patients) | |
| Yohimbine | Clonidine | Decreases blood pressure reduction effect of centrally active agents |
| Guanabenz | ||
| CNS stimulants (eg, amphetamines) | Risk of hypertensive crisis due to its monoamine oxidase inhibitor activity | |
| ACE inhibitors | Decreases effectiveness of ACE inhibitors; Hypertension |
|
| β-Blockers | Decreases effectiveness of β-blockers; Hypertension; Increases heart rate |
Abbreviations: ACE, angiotensin-converting enzyme; CNS, central nervous system; HIV, human immunodeficiency virus; PAF, platelet-activating factor.